Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPILIMUMAB vs IRINOTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPILIMUMAB vs IRINOTECAN: Safety Overview

Metric IPILIMUMAB IRINOTECAN
Total FAERS Reports 36,528 27,965
Deaths Reported 8,043 4,530
Death Rate 22.0% 16.2%
Hospitalizations 17,031 10,384
Average Patient Age 62.9 yrs 58.7 yrs
% Female Patients 35.4% 41.4%
FDA Approval Date N/A Apr 11, 2022
Manufacturer E.R. Squibb & Sons, L.L.C. Armas Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription